Friday 6 November 2026 Export PTCT’s income statement to Excel — free account

PTC Therapeutics, Inc.

PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.

Revenue: +69.6%
EPS: −409.7%
Free cash flow: +90.3%
Total debt: +19.3%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

65.55 0.12 −0.18%

Follow PTCT

Alert me

Market cap: $5.5B
P/E: 0.0×
Fwd P/E: 42.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.86
Beneish M: −1.48
Dividend safety: n/a

Overview

PTC Therapeutics, Inc. (PTCT) P/E ratio

Alert me on P/E ratio

PTC Therapeutics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 9.0× (November 2025) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PTCT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="PTC Therapeutics, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PTCT/metrics/pe-ratio">PTC Therapeutics, Inc. (PTCT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	8.6×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	8.6×	35.32%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 9.0×

Ten-year median 0.0×

Current reading's percentile 92

Company	P/E ratio
BLTE Belite Bio, Inc. Sponsored ADR compare	n/m
MIRM Mirum Pharmaceuticals, Inc. compare	n/m
CGON CG Oncology, Inc. compare	n/m
SRRK Scholar Rock Holding Corporation compare	n/m
MANE Veradermics Incorporated compare	n/m
IMVT Immunovant, Inc. compare	n/m
PTCT PTC Therapeutics, Inc.	n/m
KOD Kodiak Sciences Inc. compare	n/m
COGT Cogent Biosciences, Inc. compare	n/m
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

PTC Therapeutics, Inc. (PTCT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PTCT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PTCT

Stockrow Weekly